AstraZeneca to acquire Alexion in $39 billion deal

Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca
American Depositary Shares per Alexion share.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-to-acquire-alexion-in-39-billion-deal/articleshow/79697059.cms

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online